✓ Last verified: January 30, 2026 — Edited & verified by Angelica Bottaro for HealingMaps Editorial Staff

Known For: Clinician-founded psychedelic therapy center combining ketamine-assisted psychotherapy with integration support, co-founded by a psychiatrist and licensed therapist
| Google Reviews | 5.0 ★ (limited reviews) |
| Location | Los Angeles, CA (Larchmont) |
| Address | 522 N Larchmont Blvd, Los Angeles, CA 90004 |
| Phone | (213) 444-5309 |
| Website | psychedelicsci.com |
| Treatments | Ketamine-Assisted Psychotherapy (KAP), IV Ketamine, Integration Therapy |
| Conditions | Depression, PTSD, Anxiety, Chronic Pain, Trauma |
| Cost | $550 initial eval | $600/session KAP | $250/session integration |
| Insurance | Not accepted (superbill provided for out-of-network reimbursement) |
| KAP Available | Yes |
| Clinical Lead | Dr. Cole J. Marta & Brooke Balliett, LMFT |
HealingMaps Take: The California Center for Psychedelic Therapy (now operating as Psychedelic Science Institute) is a clinician-founded practice that pairs ketamine with structured psychotherapy rather than offering infusions alone. Co-founded by Dr. Cole Marta and therapist Brooke Balliett, the center emphasizes the therapeutic relationship as central to the healing process. Their KAP model follows a preparation-journey-integration framework similar to clinical trial protocols for psychedelics.
Market Position: California Center for Psychedelic Therapy offers the full ketamine-assisted psychotherapy (KAP) protocol alongside medical-only ketamine dosing — one of the more integrated treatment menus in the Angeles metro.
Industry pricing reference. California Center for Psychedelic Therapy’s posted price: $550 initial eval | $600/session KAP | $250/session integration. Contact the clinic for any package or sliding-scale options. The calculator above shows metro-level cost estimates across protocols.
| Protocol | Typical Industry Cost | Offered Here |
|---|---|---|
| IV Ketamine | $350–$650/session | ✓ Yes |
| Spravato (esketamine) | $0–$250 copay (insured) | — |
| IM Ketamine | $250–$400/injection | — |
| KAP (with therapist) | $400–$1,200/session | ✓ Yes |
| At-home troches | $150–$300/month | — |
This 5-question summary is matched to the protocols and conditions California Center for Psychedelic Therapy treats. Editorial responses are HealingMaps-authored, grounded in our 2026 Ketamine Clinic Intelligence Report.
California Center for Psychedelic Therapy offers IV ketamine and KAP — a 2-protocol practice. Patients can switch between or combine modalities without changing providers. Confirm specific dosing schedules and which protocols are recommended for your condition during your consult.
Yes — California Center for Psychedelic Therapy offers KAP, which combines ketamine dosing with structured psychotherapy during the dissociative window. KAP sessions are longer than standalone infusions and priced accordingly. A reasonable consult question: whether KAP is delivered by a single integrated provider, or by a separate therapist working with the prescribing clinician.
California Center for Psychedelic Therapy treats depression via IV ketamine (off-label, evidence-based), and KAP for trauma-anchored depression. Insurance coverage is rare for IV/KAP — most patients pay out of pocket. TRD is typically defined as two or more prior antidepressant trials without sufficient response — patients meeting that bar are best candidates here.
Yes — California Center for Psychedelic Therapy treats chronic pain. They use IV ketamine for pain, which typically means longer infusion times and higher cumulative doses than mental-health protocols. Common indications include complex regional pain syndrome (CRPS), fibromyalgia, and certain neuropathic pain syndromes. Pain pricing varies significantly by structure: per-infusion vs. multi-day inpatient packages — verify how this clinic structures their billing.
Yes — California Center for Psychedelic Therapy treats anxiety, including generalized anxiety, social anxiety, and panic disorder. The evidence base for ketamine in anxiety is less robust than for depression, but it can be a meaningful option for patients who haven’t responded to SSRIs or benzodiazepines. Worth asking which of their protocols they typically recommend for anxiety-primary patients.
Leave a Reply